Completed
The Headache Inducing Effects of Cilostazol on Migraine Patients
What is being tested
Cilostazol
+ Placebo
Drug
Who is being recruted
Brain Diseases+3
+ Central Nervous System Diseases
+ Nervous System Diseases
From 18 to 60 Years
+6 Eligibility Criteria
How is the trial designed
Services Research Study
Placebo-Controlled
Interventional
Study Start: April 2013
Summary
Principal SponsorDanish Headache Center
Last updated: June 6, 2014
Sourced from a government-validated database.Claim as a partner
Study start date: April 1, 2013
Actual date on which the first participant was enrolled.We will use Cilostazol as a tool to investigate its headache inducing effects in migraine patients.
Principal SponsorDanish Headache Center
Last updated: June 6, 2014
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
14 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Services Research Study
These studies look at how healthcare is delivered, managed, and organized. They aim to improve care quality, patient experience, and access to treatment.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.From 18 to 60 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesHeadache DisordersHeadache Disorders, PrimaryMigraine Disorders
Criteria
2 inclusion criteria required to participate
Diagnosed with migraine without aura according to the IHS criteria from 2004
Healthy besides migraine
4 exclusion criteria prevent from participating
History of vascular diseases or psychiatric diseases
Other types of primary headaches
Pregnancy
Tension-type headache more than 3 days per month
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
Active ComparatorCapsule of Cilostazol 200 mg are taken orally on each study day
Group II
PlaceboA capsule of placebo containing starch are taken orally on each study day.
Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Danish Headache Center & Department of Neurology
Copenhagen, DenmarkOpen Danish Headache Center & Department of Neurology in Google MapsCompletedOne Study Center